Does RISANKIZUMAB-RZAA Cause Visual field defect? 9 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Visual field defect have been filed in association with RISANKIZUMAB-RZAA. This represents 0.0% of all adverse event reports for RISANKIZUMAB-RZAA.
9
Reports of Visual field defect with RISANKIZUMAB-RZAA
0.0%
of all RISANKIZUMAB-RZAA reports
0
Deaths
3
Hospitalizations
How Dangerous Is Visual field defect From RISANKIZUMAB-RZAA?
Of the 9 reports, 3 (33.3%) required hospitalization, and 1 (11.1%) were considered life-threatening.
Is Visual field defect Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Visual field defect?
ADALIMUMAB (155)
FINGOLIMOD (141)
HYDROXYCHLOROQUINE (128)
AFLIBERCEPT (114)
VIGABATRIN (110)
LEVONORGESTREL (105)
BEVACIZUMAB (101)
TOPIRAMATE (86)
METHOTREXATE (85)
RANIBIZUMAB (80)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Visual field defect Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA